Therapeutic monoclonal anti-tirc7 antibodies for use in...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 31/7088 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 29/00 (2006.01) C07H 21/00 (2006.01) C07K 7/08 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2486689

Provided are specific antibodies against T-cell immune response cDNA7 (TIRC7) costimulatory molecule, which are capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs). In particular, high affinity monoclonal and chimeric anti~TIRC7 antibodies are described. Compositions comprising such antibodies and their use for the treatment of immune diseases are provided.

L'invention porte sur des anticorps spécifiques contre une molécule co-stimulatrice de l'ADNc7 (TIRC7) d'une réponse immune des lymphocytes T, ces anticorps étant capables d'inhiber la prolifération des cellules mononucléaires du sang périphérique. L'invention porte également sur des anticorps anti-TIRC7 monoclonaux et chimères de haute affinité, et sur des compositions comprenant ces anticorps et leur utilisation dans le traitement des maladies immunes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic monoclonal anti-tirc7 antibodies for use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic monoclonal anti-tirc7 antibodies for use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic monoclonal anti-tirc7 antibodies for use in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1426025

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.